OLUWAKEMI BALOGUN: Open Payments
NPI 1962963389 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$771 in 22 payments from 8 companies in 2025. Trend: 2023 $335 · 2024 $152 · 2025 $771
Food & beverage: $771
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $226 |
| Indivior Inc. | 6 | $144 |
| Exact Sciences Corporation | 3 | $139 |
| Alkermes, Inc. | 1 | $120 |
| Novo Nordisk Inc | 3 | $66 |
| ABBVIE INC. | 1 | $33 |
| Astellas Pharma US Inc | 1 | $25 |
| Globus Medical, Inc. | 1 | $17 |
Products named: AIRSUPRA, SUBLOCADE, VIVITROL, The Cologuard Plus Collection Kit, BREZTRI, VRAYLAR, Veozah, Cologuard Collection Kit.
Industry payments across MD — which companies pay providers there.
